OncoSec Receives CE Mark Certification for its Commercial Electroporation Device "GenPulse(TM)" for the Treatment of Solid Tumors

CE mark enables commercialization of GenPulse™ in EU PENNINGTON, N.J. and SAN DIEGO, April 14, 2021 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a biotechnolog... Devices, Oncology, Regulatory OncoSec Medical, GenPulse, electroporation, gene delivery device
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news